<DOC>
	<DOCNO>NCT00706069</DOCNO>
	<brief_summary>This study evaluate toxicity secondary efficacy combination vinorelbine plus capecitabine metastatic breast cancer patient</brief_summary>
	<brief_title>Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer</brief_title>
	<detailed_description>The combination capecitabine-vinorelbine , iv administration vinorelbine , study phase [ I ] / [ II ] , favourable profile toxicity pretreated patient anthracyclines and/or taxanes ( Oncology News International vol 12 , 3 , suppl 2 , 2003 ) . In study toxicity effectiveness , Vanhopher report objective response rate ( PR ) 21 45 patient ( 47 % ) stabilization disease ( SD ) 16 patient ( 36 % ) . Severe leucopenia ( grade 4 ) , report 5 % patient ( Borquez D , et al : Proc Am Soc Clin Oncol 19 : Abstract 420 , 2000 )</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Histologically confirm metastatic breast cancer Age 1875 year Bidimensionally measurable evaluable disease Performance status ( PS ) 02 ( ECOG ) Patients reproductive potential must use adequate contraceptive method ( e.g. , abstinence , intrauterine device , oral contraceptive , barrier device spermicide , surgical sterilization ) treatment three month complete treatment Adequate liver ( serum bilirubin &lt; 1.5 time upper normal limit , AST ALT &lt; 2.5 time UNL absence demonstrable liver metastasis , &lt; 5 time upper normal limit presence liver metastasis ) ; adequate renal function ( serum creatinine &lt; 1.5 time upper normal limit ) ; adequate bone marrow function ( neutrophils ≥ 1.5x 109 /L , platelet ≥ 100x 109 /L ) At least three week completion irradiation Life expectancy ≥ 12 week Patients able take oral medication write informed consent Active infection Brain metastases History significant cardiac disease ( unstable angina , congestive heart failure , myocardial infarction within previous 6 month , ventricular arrhythmia ) Malnutrition ( loss ≥ 20 % original body weight ) Psychiatric illness social situation would preclude study compliance Pregnant lactating woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Metastatic Breast Cancer</keyword>
	<keyword>Vinorelbine oral</keyword>
	<keyword>Capecitabine</keyword>
</DOC>